Chargement en cours...
Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia
B-cell chronic lymphocytic leukaemia (B-CLL) remains an incurable disease due to the high risk of relapse, even after complete remission, raising the need to control and eliminate residual tumor cells in long term. Adoptive T cell therapy with genetically engineered specificity is thought to fulfil...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Hindawi Publishing Corporation
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3152962/ https://ncbi.nlm.nih.gov/pubmed/21837241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/595060 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|